热门资讯> 正文
ALT、CYCC和DB均为盘前输家
2024-04-29 20:17
- Losers: Clever Leaves Holdings (CLVR) -61% announces Voluntary Delisting and SEC Deregistration.
- Addex Therapeutics Ltd (ADXN) -52% provides update on ADX71149 phase 2 Epilepsy study.
- Cyclacel Pharmaceuticals (CYCC) -21%.
- Nature Wood Group Ltd (NWGL) -15%.
- mF International Ltd (MFI) -14%.
- Biodexa Pharmaceuticals (BDRX) -11%.
- Avenue Therapeutics (ATXI) -11% announces exercise of warrants for $4.4 Million in gross proceeds.
- reAlpha Tech Corp. (AIRE) -10%.
- Nuzee (NUZE) -9%.
- Deutsche Bank (DB) -8%.
- Blue Hat Interactive Entertainment Technology (BHAT) -8%.
- Lichen China Ltd (LICN) -7%.
- Altimmune (ALT) -6%.
- Hub Cyber Security Ltd (HUBC) -5%.
- Daqo New Energy Corp (DQ) -5% after Q1 earnings release.
More on pre-market losers & stocks.
- Deutsche Bank AG (DB) Q1 2024 Earnings Call Transcript
- Deutsche Bank May Knock Q1 Estimates Out Of The Park
- Buy Altimmune's Potential Market Disruption With Pemvidutide
- Deutsche Bank reports 10%Y/Y growth in net profit; to increase share repurchases, dividends by at least 50% in 2024
- Deutsche Bank Q1 2024 Earnings Preview
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。